A Study to Evaluate Safety and Immunogenicity of a COVID-19 Vaccine in People Living With HIV at Risk for SARS-CoV-2 (COVID-19)

Clinical trial NCT05112848 · COMPLETED

Trial details

NCT number: NCT05112848
Sponsor: Novavax
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

SARS-CoV-2 Infection

Start date: 2022-02-28
Primary completion: 2022-05-23
Enrollment: 384

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.